Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127096062 | 12709606 | 2 | F | 20160314 | 20160317 | 20160825 | 20160825 | PER | US-PERRIGO-16US014361 | PERRIGO | 57.84 | YR | M | Y | 77.98000 | KG | 20160825 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127096062 | 12709606 | 1 | PS | NICOTINE POLACRILEX | NICOTINE | 1 | Buccal | 2 MG, 4 TO 6 TIMES DAILY | Y | 2FE1238 | 90711 | LOZENGE | |||||||
127096062 | 12709606 | 2 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | UNK | U | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127096062 | 12709606 | 1 | Smoking cessation therapy |
127096062 | 12709606 | 2 | Hypertension |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127096062 | 12709606 | Abdominal pain | |
127096062 | 12709606 | Expired product administered | |
127096062 | 12709606 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127096062 | 12709606 | 1 | 20160315 | 0 |